Form D · Pharmaceuticals
Veana Therapeutics, Inc.
Portland, OR · CIK 0001741217
Offering snapshot reported Nov 13, 2020 · SEC filing
- Reported sold
- $831K Offering amount: $1.27M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 21, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 13, 2020 | Initial | $830,998 | No comparison | 4 | SEC filing |
| May 21, 2018 | Initial | $542,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04, 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-380485
Source: Form D, filed Nov 13, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rebecca Akporiaye | Director, Executive |
| Emmanuel Akporiaye | Director, Executive |
| Denis R Burger | Director |
| Trent D Davis | Director |
| Mark F Holifer | Director, Executive, Promoter |
| Thomas E Mc Chesney | Executive |
| Bruce Ramseyer | Director |
| F Andrew Ray | Director |
| Andrew Ray | Director |
| Sandra Shotwell | Director |
| Andrew D Thaler | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9398 Sw Washington Street
Portland, OR, 97225
Portland, OR, 97225